within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01B_Antimetabolites.L01BC02_Fluorouracil;

model Fluorouracil
  extends Pharmacolibrary.Drugs.ATC.L.L01BC02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01BC02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Fluorouracil (5-FU) is an antimetabolite chemotherapeutic agent widely used in the treatment of various cancers, including colorectal, breast, gastric, pancreatic, and head and neck cancers. It interferes with DNA synthesis and cell division by inhibiting thymidylate synthase. 5-FU has been used for decades and remains an important drug in oncology, typically administered intravenously.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult cancer patients receiving intravenous 5-FU.</p><h4>References</h4><ol><li><p>Diasio, RB, &amp; Harris, BE (1989). Clinical pharmacology of 5-fluorouracil. <i>Clinical pharmacokinetics</i> 16(4) 215–237. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198916040-00002&quot;>10.2165/00003088-198916040-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2656050/&quot;>https://pubmed.ncbi.nlm.nih.gov/2656050</a></p></li><li><p>Ismael, G, et al., &amp; Jackisch, C (2012). Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial. <i>The Lancet. Oncology</i> 13(9) 869–878. DOI:<a href=&quot;https://doi.org/10.1016/S1470-2045(12)70329-7&quot;>10.1016/S1470-2045(12)70329-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22884505/&quot;>https://pubmed.ncbi.nlm.nih.gov/22884505</a></p></li><li><p>De Bruijn, EA, et al., &amp; Tjaden, UR (1988). Pharmacokinetics of intravenous and oral cyclophosphamide in the presence of methotrexate and fluorouracil. <i>Pharmaceutisch weekblad. Scientific edition</i> 10(5) 200–206. DOI:<a href=&quot;https://doi.org/10.1007/BF01956871&quot;>10.1007/BF01956871</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3205676/&quot;>https://pubmed.ncbi.nlm.nih.gov/3205676</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Fluorouracil;
